BIO
TechnologyBio-Rad Laboratories Inc - Class A
Live · NYSE · May 9, Close
What's Moving BIO Today?
No stock-specific AI insight has been generated for BIO yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Trading
BIO News
21 articles- Bio-Rad to Participate in Upcoming Investor ConferencesYahoo Finance·May 8, 2026
- Ariel Investments Re-added Bio-Rad Laboratories (BIO) as Strong Margins and Market Leadership Stand OutYahoo Finance·May 5, 2026
- [Latest] Global Targeted DNA RNA Sequencing Market Size/Share Worth USD 46.9 Billion by 2035 at a 18.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)Yahoo Finance·May 4, 2026
- How The Biocon (NSEI:BIOCON) Story Is Shifting As Analysts Recut Growth And Risk AssumptionsYahoo Finance·May 4, 2026
- Bio-Rad (BIO) Q2 2025 Earnings Call TranscriptMotley Fool·May 4, 2026
- Unlocking Bio-Rad (BIO) International Revenues: Trends, Surprises, and ProspectsYahoo Finance·May 4, 2026
- Bio-Rad (BIO) Q1 2026 Earnings TranscriptMotley Fool·May 1, 2026
- Bio-Rad Laboratories, Inc. Q1 2026 Earnings Call SummaryMoby·May 1, 2026
- Bio-Rad Laboratories Inc (BIO) Q1 2026 Earnings Call Highlights: Navigating Challenges with ...Yahoo Finance·May 1, 2026
- Bio-Rad Laboratories Q1 Earnings Call HighlightsMarketbeat·May 1, 2026
- Bio-Rad Laboratories (BIO) Lags Q1 Earnings EstimatesYahoo Finance·Apr 30, 2026
- Bio-Rad Reports First-Quarter 2026 Financial ResultsYahoo Finance·Apr 30, 2026
- Saudi Arabia In-Vitro Diagnostics (IVD) Market Report 2025-2034 Featuring Roche, Danaher, Abbott Laboratories, Thermo Fischer Scientific, Bio-Rad Laboratories, Sysmex, BD & Co, and BiomerieuxYahoo Finance·Apr 28, 2026
- Bio-Rad Laboratories, Inc. (BIO) PT Reduced to $300 by Citigroup Amid Process Chromatography ConcernsYahoo Finance·Apr 24, 2026
- Bio-Rad to Report First-Quarter 2026 Financial Results on Thursday, April 30, 2026Yahoo Finance·Apr 16, 2026
- Araceli Biosciences Appoints Christine Tsingos to Board of DirectorsYahoo Finance·Apr 16, 2026
- Is It Time To Consider Buying Biome Australia Limited (ASX:BIO)?Yahoo Finance·Apr 7, 2026
- Here Are Tuesday’s Top Wall Street Analyst Research Calls: Ameriprise Financial, Arista Networks, Arm Holdings, Lennar, Morgan Stanley, Rocket Lab, Tractor Supply, Wingstop, Wix.com and More247 Wall St·Apr 7, 2026
- How Recent Shifts Are Reframing The Biocon (NSEI:BIOCON) Investment NarrativeYahoo Finance·Apr 5, 2026
- Drug Screening Market Trends 2026–2031: Chromatography and Mass Spectrometry Held a 44.77% Share in 2025 Amid Growing Demand for Advanced Testing, Reports Mordor IntelligenceGlobeNewswire Inc.·Apr 3, 2026
- Artisan Mid Cap Value Fund Sold Bio-Rad Laboratories (BIO) in Q4Yahoo Finance·Apr 1, 2026
All 21 articles loaded
Price Data
Fundamentals
Trading
About Bio-Rad Laboratories Inc - Class A
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.